Results 101 to 110 of about 11,604 (173)

Effect of Interleukin-6 Inhibitors on Rheumatoid Arthritis Pain: Overview of Evidence and Mechanistic Pathways. [PDF]

Pharmacol Res Perspect
Belančić A, Sener S, Fajkić A, Potočnjak I, Benić MS, Vučković M, Sener YZ, Pavlović MR, Markotić A, Radić J, Radić M.   +10 more
europepmc   +1 more source

Skeletal muscle expression of the genes associated with glycoprotein 130 signaling in relation to obesity and insulin sensitivity. [PDF]

J Endocrinol Invest
Danowska M, Nikołajuk A, Strączkowski M.   +2 more
europepmc   +1 more source

Non-canonical IL‑22 receptor signaling remodels the oral mucosal barrier during Candida albicans immunosurveillance. [PDF]

Nat Commun
Millet N, Sekar J, Solis NV, Miao J, Millet A, Aggor FEY, Wildeman A, Cook ME, Davari A, Peters BM, Lionakis MS, Gaffen SL, Jendzjowsky N, Filler SG, Swidergall M.   +14 more
europepmc   +1 more source

Snapshot Look at Castleman Disease. [PDF]

J Cell Mol Med
Jitaru C, Zlampa N, Dima D, Bojan A, Zdrenghea M, Urian L, Kegyes D, Bancos A, Santa M, Ivancuta A, Petrushev B, Nistor M, Tigu B, Constantinescu C, Fetica B, Puiu M, Muresan MS, Tomuleasa C.   +17 more
europepmc   +1 more source

Human germline biallelic loss-of-function <i>OSMR</i> variants cause severe allergic disease. [PDF]

J Hum Immun
Samra S, Sharma M, Körholz J, Liu Y, James A, Michalski C, Yousefi P, Del Bel KL, Lu HY, Sharma AA, Tarailo-Graovac M, Dalmann J, Buder L, Modi B, Wiedemuth R, Golding L, Drögemöller B, Blanchard-Rohner G, Senger C, Rehmus W, Prendiville JS, Mangino M, Ross CJ, van Karnebeek CDM, Wasserman WW, D Rosenzweig S, Niemela J, Lavoie PM, Prathibha PM, Wegehaupt O, Biggs CM, Boehnke M, Kinnunen L, Koistinen HA, McKinnon ML, Breuer JM, Schönenkorb J, Brock R, Thull S, Netzer C, Velmans C, Altuwaijri N, Hamadah IR, Altassan R, Alfares A, Maddirevula S, Patil SJ, Bayer DK, Lyons JJ, Turvey SE.   +49 more
europepmc   +1 more source

Interleukin-35 as a key immunoregulatory mediator in steroid-hyporesponsive severe asthma. [PDF]

Front Immunol
Al-Matouq J, Khalid Salah Al-Sheakly B, Saheb Sharif-Askari N, Halwani R, Saheb Sharif-Askari F.   +4 more
europepmc   +1 more source

IL‑6: A key player in the EGFR‑TKI‑resistant tumor microenvironment and its therapeutic implications (Review). [PDF]

Int J Oncol
Wei Q, Huang C, Zhang Y, Zeng H, Qi C, Tan S, Li W, Tian P, Li Y.   +8 more
europepmc   +1 more source

Soluble gp130 inhibits Th17 polarization in neutrophilic asthma by blocking IL-6 <i>trans</i>-signaling in dendritic cells. [PDF]

Front Immunol
Zhu S, Yao Y, Lv T, Yao F, Xu J, Zhang A, Zhang F.   +6 more
europepmc   +1 more source

IL-6/GP130/JAK/STAT3 Pathway Activation in Pancreatic Ductal Adenocarcinoma and Its Association With Clinical Features: Protocol for a Retrospective Cross-Sectional Study. [PDF]

JMIR Res Protoc
Mellenthin C, Schaller F, Vignot L, Peisl S, Vesce R, Esposito I, Gonelle-Gispert C, Schneider C, Adamina M, Bühler LH.   +9 more
europepmc   +1 more source

Interleukin-6 in Natural and Pathophysiological Kidney Aging. [PDF]

Cells
Mutig K, Singh PB, Lebedeva S.
europepmc   +1 more source